DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.23 -0.12 (-1.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Change in Accured Expenses (2018 - 2026)

Updated

DiaMedica Therapeutics' Change in Accured Expenses came in at $1.3 million for Q2 2026, compared with -$328,000 a year earlier.

Analysis

DiaMedica Therapeutics (DMAC) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, DiaMedica Therapeutics reported Change in Accured Expenses of $823,000, up 90.1% year-over-year; for FY2025, it was -$892,000.

  • Going back by year, Change in Accured Expenses was $2.49 million in FY2024 (+615.2%), $348,000 in FY2023 (-4.9%), $366,000 in FY2022 (+771.4%) and $42,000 in FY2021.
  • The Q2 2026 figure represents the highest quarterly Change in Accured Expenses in data going back to Q1 2018.
  • Year-over-year, Change in Accured Expenses increased in two of the last four quarters, with growth averaging 79.8%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q2 2024 (growth of 936.8%), and the weakest in Q4 2025 (a decline of 78.3%).
  • Business Quant data shows DMAC's Change in Accured Expenses at -$1.23 million (Q1 2026), $282,000 (Q4 2025) and $469,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.20 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 338.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 222.50 Mn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - 1.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.30 Mn
Mar 31, 2026 -1.23 Mn
Dec 31, 2025 282,000.00
Sep 30, 2025 469,000.00
Jun 30, 2025 -328,000.00
Mar 31, 2025 -1.32 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 775,000.00
Jun 30, 2024 394,000.00
Mar 31, 2024 19,000.00
Dec 31, 2023 530,000.00
Sep 30, 2023 198,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 -418,000.00
Dec 31, 2022 737,000.00
Sep 30, 2022 -265,000.00
Jun 30, 2022 -90,000.00
Mar 31, 2022 -16,000.00
Dec 31, 2021 90,000.00
Sep 30, 2021 -287,000.00
API Access

DiaMedica Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=DMAC&period=max&api_key=YOUR_API_KEY